Alvotech (NASDAQ:ALVOW – Get Free Report) was the target of a large decline in short interest in the month of May. As of May 15th, there was short interest totaling 601 shares, a decline of 41.8% from the April 30th total of 1,032 shares. Based on an average trading volume of 4,491 shares, the days-to-cover ratio is presently 0.1 days.
Alvotech Stock Performance
Shares of NASDAQ ALVOW opened at $0.23 on Thursday. Alvotech has a fifty-two week low of $0.12 and a fifty-two week high of $3.00. The stock has a fifty day moving average of $0.25 and a 200-day moving average of $0.44.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Read More
- Five stocks we like better than Alvotech
- From Runway to Riches: Victoria’s Secret’s New Look
- Fifth Third’s Big Bet Is On
- Dell’s AI Toll Bridge Is Paved with Record Margins
- As AI Data Breaches Become More Common, This Cybersecurity ETF Is Surging
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
